Apollo made a net profit of Rs 83.2 crore during the quarter as against Rs 55.8 crore in Q2 of 2011-12. The income grew from Rs 699 crore in Q2 of 2011-12 to Rs 836 crore in the last quarter.
Revenue from the hospital division grew by 13.7 per cent to Rs 558 crore, while the standalone pharmacies posted a revenue growth of 33 per cent to Rs 277 crore during the quarter against the same period last year.
Prathap C Reddy, chairman of Apollo Hospitals said, “The rising maturity of newer facilities and a focus on complex treatments through the ‘Centres of Excellence’ initiative have led to balanced growth. The improving performance of our pharmacy & health insurance businesses is resulting in a significantly improved contribution.
While the regulatory framework has become more conducive, we expect progress in a calibrated manner to enable us to balance growth and profitability while positioning ourselves to realise the long-term potential of these businesses”.